Literature DB >> 16517906

Application of UL144 molecular typing to determine epidemiology of cytomegalovirus infections in preterm infants.

R Stranska1, R Schuurman, M Toet, M Verboon-Maciolek, L S de Vries, A M van Loon.   

Abstract

Sequence analysis of the UL144 gene of human cytomegalovirus (CMV) was used to investigate the epidemiology of CMV infections in preterm infants. Nosocomial transmission of CMV from congenitally infected infant to preterm twins was excluded based on distinct molecular profiles of CMV strains. Indistinguishable molecular profiles between strains from the mother and the infant indicated postnatal acquisition of CMV through breastfeeding.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16517906      PMCID： PMC1393077          DOI： 10.1128/JCM.44.3.1108-1110.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes.

Authors:  S W Chou; K M Dennison
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

2.  Cytomegalovirus infection in newborns and their family members: polymerase chain reaction analysis of isolates.

Authors:  I E Souza; A Gregg; D Pfab; J D Dawson; P Benson; M E O'Neill; J R Murph; S J Petheram; J F Bale
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

3.  Cytomegalovirus reinfection in young children.

Authors:  J F Bale; S J Petheram; I E Souza; J R Murph
Journal:  J Pediatr       Date:  1996-03       Impact factor: 4.406

4.  Sequelae of maternally derived cytomegalovirus infections in premature infants.

Authors:  A S Yeager; P E Palumbo; N Malachowski; R L Ariagno; D K Stevenson
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

5.  Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.

Authors:  N S Lurain; K S Kapell; D D Huang; J A Short; J Paintsil; E Winkfield; C A Benedict; C F Ware; J W Bremer
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding.

Authors:  K Hamprecht; J Maschmann; M Vochem; K Dietz; C P Speer; G Jahn
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

7.  Human cytomegalovirus a sequence and UL144 variability in strains from infected children.

Authors:  J F Bale; S J Petheram; M Robertson; J R Murph; G Demmler
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

8.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Analysis of acquired human cytomegalovirus infections by polymerase chain reaction.

Authors:  J F Bale; M E O'Neil; S S Fowler; J R Murph
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Comparative analysis of human cytomegalovirus a-sequence in multiple clinical isolates by using polymerase chain reaction and restriction fragment length polymorphism assays.

Authors:  J A Zaia; G Gallez-Hawkins; M A Churchill; A Morton-Blackshere; H Pande; S P Adler; G M Schmidt; S J Forman
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948
View more
  6 in total

1.  Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.

Authors:  M Zhang; K Howard; A Winters; S Steavenson; S Anderson; S Smelt; G Doellgast; C Sheelo; J Stevens; H Kim; A Hamburger; A Sein; D J Caughey; F Lee; H Hsu; G Siu; F R Byrne
Journal:  Clin Exp Immunol       Date:  2010-11-16       Impact factor: 4.330

2.  Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection.

Authors:  Allison Waters; Jaythoon Hassan; Cillian De Gascun; Ghia Kissoon; Susan Knowles; Eleanor Molloy; Jeff Connell; William W Hall
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

3.  Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.

Authors:  E Paradowska; M Studzińska; D Nowakowska; J Wilczyński; M Rycel; P Suski; Z Gaj; B Kaczmarek; Z Zbróg; Z J Leśnikowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

4.  Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice.

Authors:  Durdica Cekinović; Mijo Golemac; Ester Pernjak Pugel; Jelena Tomac; Luka Cicin-Sain; Irena Slavuljica; Russell Bradford; Sonja Misch; Thomas H Winkler; Michael Mach; William J Britt; Stipan Jonjić
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

5.  Genotype distribution, viral load and clinical characteristics of infants with postnatal or congenital cytomegalovirus infection.

Authors:  Joppe Nijman; Femke S Mandemaker; Malgorzata A Verboon-Maciolek; Susan C Aitken; Anton M van Loon; Linda S de Vries; Rob Schuurman
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

6.  Cytomegalovirus Genotype Distribution Among Congenitally and Postnatally Infected Patients: Association of Particular Glycoprotein (g)B and gN Types With Symptomatic Disease.

Authors:  Patricia Brañas; Daniel Blázquez-Gamero; Alberto Galindo; Columbiana Prieto; Iciar Olabarrieta; Irene Cuadrado; Lola Folgueira
Journal:  Open Forum Infect Dis       Date:  2015-10-07       Impact factor: 3.835
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.